MIT Sloan BioInnovations Conference to focus on such topics as precision medicine, Big Data

This photo of George Church was included with the conference’s media advisory.
This photo of George Church was included with the conference’s media advisory.

An MIT Sloan BioInnovations Conference set for Feb. 28 plans to bring together industry, academic, and policy leaders to address trends and new approaches to precision medicine along with the impact of big data on health care, innovative financing, and new opportunities in emerging markets.

Scheduled keynote speakers include Margaret Hamburg, commissioner of the Food and Drug Administration; George Church of the Wyss Institute of Synthetic Biology and director of the Personal Genome Project; Alex Azar, president of Lilly USA, a unit of Eli Lilly and Co.; and Kieran Murphy, president and chief executive of GE Healthcare Life Sciences, conferenec officials said in a media advisory issued Wednesday.

One of several panels planned for the conference is titled, “Big Data in Health Care: Where Does That Lead Us?” It is set to examine “the wealth of opportunities and challenges brought on by Big Data, and how players in the health care industry are seeking to capitalize on this information to help drive more innovation to improve health care outcomes,” conference officials said in a media advisory.

Advertisement - Continue Reading Below

The conference will be held at the Boston Marriott Cambridge hotel in Kendall Square.